HARRISBURG, Pa. — The Pennsylvania Department of Health said it has notified all COVID-19 vaccine providers to resume using the Johnson & Johnson COVID-19 vaccine. The news follows the announcement that the CDC and FDA had lifted a pause on using the vaccine after several cases of severe blood clots had come to light. The CDC’s Advisory Committee on Immunization Practices held an emergency meeting Friday to determine the incidents were “extremely rare” and that the vaccine was safe and effective. The cases of the rare blood clots with low platelet counts occurred in women mostly between the ages of 18 and 48 out of the nearly 7 million Americans who received the vaccine. In Pennsylvania, only 271,132 people have been vaccinated with the Johnson & Johnson single-dose vaccine.